FDA approves new high dose Spinraza regimen for SMA
Updated dosing offers meaningful clinical benefit
Read More
Author: John Pinching
Viridian reports positive results from elegrobart phase 3 trial
Company says treatment shows strong efficacy and convenient dosing profile
Read More
Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
Specialist group to review preclinical and clinical proposals ahead of funding decision
Read More
Kygevvi approved in Europe as first treatment for TK2d
European Commission authorises therapy for children and adults with early‑onset disease
Read More
Tozorakimab shows significant benefit in two major COPD trials
Phase 3 studies report meaningful reductions in exacerbations across broad patient groups
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
